The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi

Promoter bought stakePromoter holding below 50%Ownership Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.8%Reaction day

₹20.99

prior close

—

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.9%-0.9% vs market

Pharmaceuticals peers, median of 155sector-2.5%-1.3% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 1.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.8-2.9-0.9-2.5-1.3

Next day

-1.4-3.5+2.1-3.3+1.9

-8.3-2.5-5.8-2.8-5.5

-4.7+0.1-4.8-2.3-2.5

+0.0-2.7+2.7-3.5+3.5

+2.0-1.9+3.8-2.9+4.8

+0.0-3.7+3.8-4.7+4.8

15d

+19.1+3.5+15.6+0.8+18.3

+13.6+5.6+8.1+2.9+10.7

-2.3+13.7-16.0+8.5-10.8

+12.0+20.0-8.1+11.2+0.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sudhir Sethi, the main promoter of Beryl Drugs Limited, acquired 4,853 equity shares (0.10%) of the company through open market transactions on 11-03-2026. His holding increased from 4,50,290 shares (8.88%) to 4,55,143 shares (8.98%) of the total share capital of 50,71,700 shares. The disclosure was filed under Regulation 29(2) of SEBI (SAST) Regulations, 2011.

Likely market impact

The promoter marginally increased his stake, signaling continued confidence in the company. However, the acquisition is very small (0.10%), so it is unlikely to materially impact the stock price.